PCRX (PCRX)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$1.31B
EV / Sales1.78
EV / EBITDA11.03
EV / Operating Cash Flow9.18
EV / Free Cash Flow9.84

Return Metrics (TTM)

Return on Equity (ROE)0.73%
Return on Assets (ROA)0.43%
Return on Invested Capital (ROIC)0.80%
Return on Capital Employed (ROCE)2.06%

Yield Metrics

Earnings Yield0.48%
Free Cash Flow Yield12.77%

Balance Sheet Strength

Net Debt / EBITDA2.25
Current Ratio4.73
Working Capital$406.17M
Tangible Asset Value$280.89M
Net Current Asset Value-$39.68M

Working Capital Efficiency

Days Sales Outstanding62.40
Days Payables Outstanding33.68
Operating Cycle (Days)423.83
Cash Conversion Cycle390.15

Capital Allocation

CapEx / Revenue1.29%
CapEx / Operating Cash Flow6.69%
R&D / Revenue16.29%
SG&A / Revenue51.16%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin79.39%
Operating Margin4.58%
Net Profit Margin0.97%

Solvency

Debt / Equity0.66
Quick Ratio3.28
Cash Ratio1.31

Per Share

Revenue / Share$16.30
FCF / Share$3.07
PE Ratio161.75